Company Information
CIN
Status
Date of Incorporation
21 August 1996
State / ROC
Chandigarh / ROC Chandigarh
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2022
Paid Up Capital
1,000,130
Authorised Capital
1,000,000,000
Directors
Sharvan Bhatt
Director/Designated Partner
over 2 years ago
over 2 years ago
Devang Manharlal Ajmera
Director/Designated Partner
about 3 years ago
about 3 years ago
Bhavin Manharlal Ajmera
Director/Designated Partner
about 4 years ago
about 4 years ago
Piyush Manharlal Ajmera
Director/Designated Partner
about 4 years ago
about 4 years ago
Arun Kumar Purwar
Director
about 13 years ago
about 13 years ago
Past Directors
Yogita Narhari Jadhav
Additional Director
almost 11 years ago
almost 11 years ago
Sanjay Kumar Randhar
Director
about 13 years ago
about 13 years ago
Rajinder Singh Gujral
Whole Time Director
over 15 years ago
over 15 years ago
Vivek Gupta
Whole Time Director
over 15 years ago
over 15 years ago
Vellore Sambamurthy Maniam
Director
over 15 years ago
over 15 years ago
Sushant Gupta
Director
over 15 years ago
over 15 years ago
Sandeep Aggarwal .
Company Secretary
over 16 years ago
over 16 years ago
Sangeeta Jain
Director
over 29 years ago
over 29 years ago
Suyog Jain
Managing Director
over 29 years ago
over 29 years ago
Patents
The invention relates to an in-situ process for the preparation of amoxicillin
trihydrate from sugarcane juice without isolation of the intermediates produced
during the reaction sequence viz penicillin G and 6-aminopenicillanic acid. The
invention provides an in-situ cost effective and environment friendly proce...
The present invention relates to a process for the preparation of isoxazolyl penicillins from sugarcane juice. The invention focuses on in-situ synthesis of isoxazolyl penicillins without isolation of the intermediates like Penicillin G and 6-APA from the reaction sequence.
An improved process for preparing ascorbic acid, wherein the said process involves the reaction of 2-keto-L-gulonic acid with an aldehyde in the presence of an inert solvent and an acid chloride.
The present invention discloses a novel process for determination of gabapentin without derivatization in bulk, pharmaceutical formulations and human urine samples by HPLC using UV detector. The same has been achieved by optimization of isocratic mobile phase, appropriate column use and HPLC performance conditions.
...
The present invention discloses a novel process for synthesis of pure Sodium 2-ethyl hexanoate which is simple, fast, cost effective, less energy consuming and more efficient. The same has been achieved by dehydrating the aqueous solution of salt and subsequent drying in a pan to obtain purified salt in fine powdere...
The invention relates to a novel process for the direct estimation of pregabalin in bulk pharmaceuticals, formulations and human urine samples with the help of High Performance Liquid Chromatography system (HPLC) using UV detector and without the need for derivatization, thus enabling fast and easy analysis of sampl...
An improved process for preparing sterile amoxicillin and an alkali metal salt thereof, wherein the said process involves the steps of: i) dissolving amoxicillin trihydrate in methyl acetate, methanol and triethylamine; ii) Passing the resulting solution through a series of filters iii) addition of mixture of sodium...
An improved process for the production of penicillins, preferably amoxicillin trihydrate, having a low concentration of halogen-containing solvents. The reaction is carried out in the presence of vacuum and simultaneous purging of an inert gas which results in lowering the concentration of solvent as an impurity pre...
The present invention relates to an improved process for the preparation of isoxazolyl penicillins of formula (I).
wherein X1 and X2 can be independently selected from the group comprising hydrogen, chlorine or fluorine, and its pharmaceutically suitable salts. The invention also focuses on an in-situ synthes...
The invention relates to a process for preparation of a premixed form of piperacillin and tazobactam. The admixture is prepared by dissolving piperacillin acid and tazobactam acid in a definite ratio in the presence of sodium ethyl hexanoate which is then crystallised under specific conditions to obtain the homogene...
Penicillanic acid 1 1-dioxide and esters thereof such as Sulbactam Sodium are used as antibacterial agents and also enhance the effectiveness of several ß-lactam antibiotics against many ß-lactamase producing bacteria. A process for the production of crystal of Sulbactam Sodium is disclosed here involving reaction ...
Charges
24 May 2014
State Bank Of Patiala
268 Crore
06 September 2012
State Bank Of Patiala
170 Crore
23 December 2011
State Bank Of Patiala
20 Crore
30 July 2011
Religare Finvest Limited
1 Crore
16 December 2010
State Bank Of Patiala
40 Crore
15 December 2010
Edelweiss Asset Reconstruction Company Limited
40 Crore
23 November 2010
State Bank Of India
40 Crore
28 June 2010
Idbi Bank Limited
25 Crore
13 March 2010
Allahabad Bank
55 Crore
08 October 2008
State Bank Of Patiala
10 Crore
03 August 2007
State Bank Of Patiala
10 Crore
28 July 2004
State Bank Of Patiala
88 Crore
27 September 2011
Punjab Reliable Investments Pvt Ltd
2 Crore
29 March 2013
Punjab Kashmir Finance Limited
1 Crore
20 August 2014
Punjab Reliable Investments Private Limited
73 Lak
19 November 2010
L & T Finance Limited
10 Crore
01 July 2011
Intec Capital Limited
3 Crore
01 July 2011
Intec Capital Limited
3 Crore
23 March 2010
State Bank Of Hyderabad
15 Crore
27 March 2007
Icici Bank Limited
2 Crore
16 August 2001
State Bank Of Patiala
35 Lak
16 August 2001
State Bank Of Patiala
30 Lak
04 August 2022
Hdfc Bank Limited
0
20 July 2022
Hdfc Bank Limited
0
15 December 2010
Edelweiss Asset Reconstruction Company Limited
0
16 August 2001
State Bank Of Patiala
0
20 August 2014
Punjab Reliable Investments Private Limited
0
23 December 2011
State Bank Of Patiala
0
16 December 2010
State Bank Of Patiala
0
28 June 2010
Idbi Bank Limited
0
23 March 2010
State Bank Of Hyderabad
0
13 March 2010
Allahabad Bank
0
08 October 2008
State Bank Of Patiala
0
16 August 2001
State Bank Of Patiala
0
01 July 2011
Intec Capital Limited
0
01 July 2011
Intec Capital Limited
0
30 July 2011
Religare Finvest Limited
0
24 May 2014
State Bank Of Patiala
0
19 November 2010
L & T Finance Limited
0
27 March 2007
Icici Bank Limited
0
29 March 2013
Punjab Kashmir Finance Limited
0
06 September 2012
State Bank Of Patiala
0
28 July 2004
State Bank Of Patiala
0
27 September 2011
Punjab Reliable Investments Pvt Ltd
0
03 August 2007
State Bank Of Patiala
0
23 November 2010
State Bank Of India
0
04 August 2022
Hdfc Bank Limited
0
20 July 2022
Hdfc Bank Limited
0
15 December 2010
Edelweiss Asset Reconstruction Company Limited
0
16 August 2001
State Bank Of Patiala
0
20 August 2014
Punjab Reliable Investments Private Limited
0
23 December 2011
State Bank Of Patiala
0
16 December 2010
State Bank Of Patiala
0
28 June 2010
Idbi Bank Limited
0
23 March 2010
State Bank Of Hyderabad
0
13 March 2010
Allahabad Bank
0
08 October 2008
State Bank Of Patiala
0
16 August 2001
State Bank Of Patiala
0
01 July 2011
Intec Capital Limited
0
01 July 2011
Intec Capital Limited
0
30 July 2011
Religare Finvest Limited
0
24 May 2014
State Bank Of Patiala
0
19 November 2010
L & T Finance Limited
0
27 March 2007
Icici Bank Limited
0
29 March 2013
Punjab Kashmir Finance Limited
0
06 September 2012
State Bank Of Patiala
0
28 July 2004
State Bank Of Patiala
0
27 September 2011
Punjab Reliable Investments Pvt Ltd
0
03 August 2007
State Bank Of Patiala
0
23 November 2010
State Bank Of India
0
Documents
Form DPT-3-12022020-signed
Form AOC-4(XBRL)-05122019_signed
Form MGT-7-05122019_signed
List of share holders, debenture holders;-02122019
Copy of MGT-8-02122019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-01122019
XBRL document in respect Consolidated financial statement-01122019
Form DPT-3-27082019
Auditor?s certificate-27082019
Form ADT-1-02072019_signed
Copy of resolution passed by the company-02072019
Copy of written consent given by auditor-02072019
Copy of the intimation sent by company-02072019
Form AOC-4(XBRL)-25012019_signed
Form MGT-7-25012019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-23012019
XBRL document in respect Consolidated financial statement-23012019
Copy of MGT-8-22012019
List of share holders, debenture holders;-22012019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-21012019
Copy of MGT-8-21012019
XBRL document in respect Consolidated financial statement-21012019
List of share holders, debenture holders;-21012019
Form INC-28-12102018-signed
Optional Attachment-(3)-05102018
Optional Attachment-(2)-05102018
Optional Attachment-(1)-05102018
Copy of court order or NCLT or CLB or order by any other competent authority.-05102018
Form AOC-4(XBRL)-10052018_signed
Form MGT-7-10052018_signed
